ZLDPF — Zealand Pharma A/S/ADR
—
OTC ·
Unknown ·
Unknown ·
CIK 2068427 ·
Denmark
Last close
$44.86
Market Cap
$3.10B
52W High
$55.36
52W Low
$38.50
ADV30
1,190
Next earnings
2026-05-07
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 34,000,000 | 34,000,000 | -539,000,000 | -394,000,000 | 15,301,000,000 | 3,849,000,000 | 832,000,000 |
| Dec 2025 | 68,915,000 | 68,915,000 | -356,544,000 | -379,115,000 | 15,948,798,000 | 4,576,541,000 | 1,118,185,000 |
| Sep 2025 | 49,569,000 | 49,569,000 | -461,320,000 | -404,233,000 | 16,797,246,000 | 5,972,711,000 | 1,634,645,000 |
| Jun 2025 | 9,088,284,000 | 9,087,874,000 | 8,338,423,000 | 7,573,697,000 | 17,180,064,000 | 7,244,047,000 | 1,571,270,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$6,531,933,000
Investing CF
$-2,248,506,000
Financing CF
$-378,182,000
CapEx
$-69,073,000
Dividends Paid
—
Buybacks
$-345,566,000
EPS Diluted TTM
$91.34
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$6,287,000
Inventory
$0
Receivables
—
ST Investments
$10,532,267,000
EBIT TTM
$7,030,122,000
Pretax Income TTM
$7,001,063,000
Interest Exp TTM
$29,059,000
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$9,240,859,648
EBITDA
$6,799,047,168
Free Cash Flow
$4,224,191,744
Enterprise Value
$-10,884,188,160
Total Cash
$14,467,999,744
Total Debt
$414,000,000
Shares Out
69,089,276
Trailing EPS
$13.58
Book Value
$31.23
ROE
56.2%
ROA
34.7%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 9,214,860,000 | 7,113,523,000 | 6,455,008,000 | 15,948,798,000 | 1,118,185,000 | — | 6,531,933,000 |
| Dec 2024 | 62,691,000 | -1,269,071,000 | -1,078,828,000 | 9,505,600,000 | 888,858,000 | — | -930,816,000 |
| Dec 2023 | 342,788,000 | -577,217,000 | -703,739,000 | 1,979,993,000 | 387,154,000 | — | -425,668,000 |
| Dec 2022 | 103,986,000 | -816,599,000 | -1,202,135,000 | 1,539,806,000 | 723,895,000 | — | -942,311,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-1.16
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| UTF | COHEN & STEERS INFRASTRUCTURE FUND INC | $3.09B | $27.68 | — |
| WRBY | Warby Parker Inc. | $3.11B | $29.05 | — |
| MGEE | MGE ENERGY INC | $3.09B | $81.77 | — |
| RCWLY | Rockwool A/S/ADR | $3.12B | $32.00 | — |
| SVYSF | SOLVAY S A /ADR/ | $3.03B | $29.00 | — |
News headlines (Yahoo Finance, 1h cache)
Zealand Pharma (CPSE:ZEAL) Stock Stays Reasonable On Earnings Yet Richer On Fair Value
2026-07-08 04:31 · Yahoo
Zealand Pharma - Transactions related to share buy-back program (week 27, 2026)
2026-07-06 15:00 · Yahoo
Brenus Pharma Strengthens Its Governance With Designation of a New President and Appointment of Former Novo Nordisk EVP as Independent Member
2026-07-02 06:00 · Yahoo
Total number of shares and voting rights in Zealand Pharma as of June 30, 2026
2026-06-30 20:01 · Yahoo
Zealand Pharma major shareholder announcement: The Capital Group Companies, Inc.
2026-06-30 20:00 · Yahoo
Zealand Pharma - Transactions related to share buy-back program (week 26, 2026)
2026-06-29 15:00 · Yahoo
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
2026-06-22 20:00 · Yahoo
Zealand Pharma - Transactions related to share buy-back program (week 25, 2026)
2026-06-22 15:00 · Yahoo
[Latest] Global GLP-1 Receptor Agonist Market Size/Share Worth USD 95.3 Billion by 2035 at a 12.1% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Grow
2026-06-16 22:30 · Yahoo
Zealand Pharma - Transactions related to share buy-back program (week 24, 2026)
2026-06-15 15:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.